Clinical end point acceptance limit [Study As­sess­ment]

posted by ElMaestro  – Denmark, 2019-04-05 08:51 (654 d 12:41 ago) – Posting: # 20126
Views: 2,183

Hello to you too, PKS,

» Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

What does your protocol say on exactly that matter?

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,303 posts in 4,441 threads, 1,487 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Monday 20:33 CET (Europe/Vienna)

I believe there is no philosophical high-road in science,
with epistemological signposts. No, we are in a jungle
and find our way by trial and error,
building our road behind us as we proceed.    Max Born

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5